Skip to main content
. 2008 Oct 14;8:296. doi: 10.1186/1471-2407-8-296

Table 4.

Subgroup analyses of association of clinical recurrence in 251 patients with PTMC according to surgical extent after excluding patients without pathologic N staging information

Baseline characteristics Patients with total or near-total thyroidectomy (n = 150) Patients with hemi- or subtotal thyroidectomy (n = 101) Overall (n = 251)



HR 95% CI P HR 95% CI P HR 95% CI P
Age at operation
 ≤ 45 yrs 1.75 0.41–7.39 0.45 INF NC 0.99 2.38 0.63–8.98 0.20
 > 45 yrs 1.00 - - 1.00 - - 1.00 - -
Gender
 Men 5.35 1.28–22.4 0.02 24.2 2.17–270 0.01 7.59 2.31–25.0 0.001
 Women 1.00 - - 1.00 - - 1.00 - -
Tumor size
 Per 1 mm increase 1.17 0.79–1.72 0.44 1.36 .0.67–2.76 0.4 1.23 0.86–1.74 0.26
Multifocality
 Solitary tumor 1.58 0.38–6.62 0.53 0.18 0.02–1.93 0.16 0.9 0.26–3.08 0.86
 Multifocal tumor 1.00 - - 1.00 - - 1.00 - -
Extrathyroid extension
 Absent 0.53 0.13–2.23 0.39 INF NC 1 0.77 0.23–2.52 0.66
 Present 1.00 - - 1.00 - - 1.00 - -
Lymph node metastasis 0.04 1 0.03
 pN0 0 NC 1 0 NC 0.99 0 NC 0.99
 pN1aa 1.00 - - 1.00 - - 1.00 - -
 pN1bb 8.25 1.66–40.9 0.01 N/A 5.14 1.56–17.0 0.007
Bilaterality
 Unilateral tumor 0.74 0.18–3.11 0.69 N/A 0.65 0.17–2.47 0.53
 Bilateral tumor 1.00 - - 1.00 - -
Remnant ablation
 Not done 0 NC 1 N/A N/A
 Done 1.00 - -

a Metastases to level VI lymph nodes (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes), classified as N1a in the 2002 TNM staging.

b Metastases to unilateral, bilateral, or contralateral cervical superior mediastinal lymph nodes, classified as N1b in the 2002 TNM staging.

Percent recurrence rates were given in parentheses; CI, confidence interval; N/A, not applicable; INF, infinite; NC, cannot calculate; HR, hazard ratio.